Počet záznamov: 1  

Neoplasma

  1.   Požičať
    NázovNeoplasma
    Podnázovjournal of experimental and clinical oncology
    Aut. údajeCancer Research Institute of the Slovak Academy of Sciences
    ISSN0028-2685
    Roč., čísloVol. 67 no. 4 (2020)
    Vyd.údajeBratislava : AEPress . - s. 715-945
    OdkazyPERIODIKÁ-Súborný záznam periodika (0.0-)
    ČLÁNKY2020:
    Adverse events and management of apatinib in patients with advanced or metastatic cancers: A review (0.0-),
    Diagnostic relevance of 18F-FDG PET/CT in newly diagnosed patients with monoclonal gammopathy of undetermined significance : Single-center experience (0.0-),
    Downregulation of nuclear protein-1 induces cell cycle arrest in G0/G1 phase in glioma cells in vivo and in vitro via P27 (0.0-),
    Effects of sarcopenia, hypoalbuminemia, and laparoscopic surgery on postoperative complications in elderly patients with colorectal cancer: A prospective study (0.0-),
    Evaluation of an amplicon-based custom gene panel for the diagnosis of hereditary tumors (0.0-),
    Hypomethylation of CTCFL promoters as a noninvasive biomarker in plasma from patients with hepatocellular carcinoma (0.0-),
    Inhibition of the breast cancer by PPARγ agonist pioglitazone through JAK2/STAT3 pathway (0.0-),
    Kallikrein-related peptidase cessation blunts colorectal cancer cell growth and glucose metabolism by regulating the PI3K/Akt/mTOR pathway (0.0-),
    LncRNA CDKN2B-AS1 promotes the progression of ovarian cancer by miR-143-3p/SMAD3 axis and predicts a poor prognosis (0.0-),
    LncRNA DSCAM-AS1 promotes non-small cell lung cancer progression via regulating miR-577/HMGB1 axis (0.0-),
    LncRNA TUG1 promotes tumor growth and metastasis of esophageal squamous cell carcinoma by regulating XBP1 via competitively binding to miR-498 (0.0-),
    Long non-coding RNA LINC00152/miR-613/CD164 axis regulates cell proliferation, apoptosis, migration and invasion in glioma via PI3K/AKT pathway (0.0-),
    miR-193a-5p suppresses cell proliferation and induces cell apoptosis by regulating HOXA7 in human ovarian cancer (0.0-),
    miR-33a-5p inhibits the growth and metastasis of melanoma cells by targeting SNAI2 (0.0-),
    miR-3662 suppresses cell growth, invasion and glucose metabolism by targeting HK2 in hepatocellular carcinoma cells (0.0-),
    miR-375 targeting autophagy-related 2B suppresses autophagy and tumorigenesis in cisplatin-resistant osteosarcoma cells (0.0-),
    O-GlcNA cylation promotes malignant phenotypes of bladder cancer cells (0.0-),
    Regulation of HBV replication and gene expression by miR-501-3p via targeting ZEB2 in hepatocellular carcinoma (0.0-),
    SKA2 promotes proliferation and invasion of hepatocellular carcinoma cells via activating the β-catenin signaling pathway (0.0-),
    SOCS2 affects the proliferation, migration, and invasion of nasopharyngeal carcinoma cells via regulating EqhA1 (0.0-),
    Study of DOK4 gene expression and promoter methylation in sporadic breast cancer (0.0-),
    The expression of CD73 on pathological B-cells is associated with shorter overall survival of patients with CLL (0.0-),
    The long non-coding RNA PVT1/miR-145-5p/ITGB8 axis regulates cell proliferation, apoptosis, migration and invasion in non-small cell lung cancer cells (0.0-),
    The tumor suppressor NOR1 suppresses cell growth, invasiveness, and tumorigenicity in glioma (0.0-),
    Upregulation of SNHG12 accelerates cell proliferation, migration, invasion and restrain cell apoptosis in breast cancer by enhancing regulating SALL4 expressionvia sponging miR-15a-5p (0.0-)
    Status periodikaprijaté (04.11.2020)
    Jazyk dok.angličtina
    KrajinaSlovenská republika
    Počet ex.2, z toho voľných 0, prezenčne 2
    Druh dok.Časopisy
    Báza dátPERIODIKÁ - Prijaté čísla
    časopis

    časopis

      Požičať
                               
    Call numberLocationSublocationInfo
    C 720
    sklad Lazaretská: časopisy r. 2005-
    		In-Library Use Only
    C 720
    sklad Lazaretská: časopisy r. 2005-
    		In-Library Use Only
Počet záznamov: 1  

  Tieto stránky využívajú súbory cookies, ktoré uľahčujú ich prezeranie. Ďalšie informácie o tom ako používame cookies.

Prijať všetkoNastavenieOdmietnuť všetko